or
forgot password
  • cancer clinical trials in pittsburgh, PA

  • PROCLAIM Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
    Hillman Cancer Research Pavilion, Div. of Medical Oncology
    Pittsburgh, Pennsylvania 15232
    Metastatic Renal Cell Carcinoma, Metastatic Melanoma
    Cancer Vaccines CRS-207 and GVAX Pancreas for Metastatic Pancreatic Adenocarcinoma
    University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213
    Pancreatic Cancer
    Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
    University of Pittsburgh University of Pittsburgh (SC)
    Pittsburgh, Pennsylvania 15232-1305
    Advanced Solid Tumors, Excluding Breast Cancer
    Combination of Weekly Paclitaxel With Neratinib and Trastuzumab in Women With Metastatic HER2-positive Breast Cancer
    University of Pittsburgh

    Trial Locations
    University of Pittsburgh
    NSABP Foundation, Inc.
    Breast Cancer
    Metformin Hydrochloride in Preventing Esophageal Cancer in Patients With Barrett Esophagus
    University of Pittsburgh Medical Center - Shadyside Hospital
    Pittsburgh, Pennsylvania 15213-2582
    Barrett Esophagus, Esophageal Cancer
    Tissue Collection Study for Patients With Non-Small Cell Lung Cancer With Resectable Disease
    University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213
    Non-Small Cell Lung Cancer
    Pediatric Philadelphia Positive Acute Lymphoblastic Leukemia
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Leukemia, Pediatric
    Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Childhood Cerebral Astrocytoma/Malignant Glioma, Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Infratentorial Ependymoma, Childhood Mixed Glioma, Childhood Oligodendroglioma, Childhood Supratentorial Ependymoma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma
    A Safety and Efficacy Study of Carfilzomib and Pomalidomide With Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
    University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Multiple Myeloma
    NBRST: Prospective Neo-adjuvant REGISTRY Trial
    St. Clair Hospital
    Pittsburgh, Pennsylvania 15243
    Breast Cancer
    Efficacy and Safety Study of NeuVax(TM)(Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
    Univerity of Pittsburgh Medical Center (UPMC) Cancer Center
    Pittsburgh, Pennsylvania 15232
    HER2 Negative Breast Cancer
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    University of Pittsburgh Medical Center, Cancer Centers
    Pittsburgh, Pennsylvania
    Colorectal Cancer
    Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
    Hillman Cancer Center at University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15236
    Brain and Central Nervous System Tumors
    Phase III Study of Rindopepimut/GM-CSF in Patients With Newly Diagnosed Glioblastoma
    University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Glioblastoma, Small Cell Glioblastoma, Giant Cell Glioblastoma, Gliosarcoma, Glioblastoma With Oligodendroglial Component
    GRN1005 Alone or in Combination With Trastuzumab in Breast Cancer Patients With Brain Metastases
    Univ. of Pittsburgh
    Pittsburgh, Pennsylvania 15232
    Breast Cancer, Brain Metastases
    Pharmacokinetics-based Mycophenolate Mofetil Dosing for GVHD Prevention
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Allogeneic Blood and Marrow Transplantation (BMT), Graft Versus Host Disease
    Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
    University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Squamous Cell Carcinoma Of The Head And Neck
    HKI-272 for HER2-Positive Breast Cancer and Brain Metastases
    UPMC Cancer Centers - Magee-Womens Hospital of UPMC
    Pittsburgh, Pennsylvania 15213
    Breast Cancer
    GRN1005 in Non-Small Cell Lung Cancer (NSCLC) Patients With Brain Metastases (GRABM-L)
    Univ. of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15232
    Non-small Cell Lung Cancer (NSCLC) With Brain Metastases
    S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer
    UPMC Cancer Centers
    Pittsburgh, Pennsylvania 15232
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer, Gastric Cancer
    Effect of Exercise and Weight Loss on Cardiovascular Health
    University of Pittsburgh
    Pittsburgh, Pennsylvania 15261
    Cardiovascular Disease, Obesity
    Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Childhood Hepatocellular Carcinoma, Papillary Thyroid Cancer, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Childhood Liver Cancer, Recurrent Childhood Rhabdomyosarcoma, Recurrent Thyroid Cancer, Recurrent Wilms Tumor and Other Childhood Kidney Tumors
    Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Childhood Mixed Glioma, Untreated Childhood Anaplastic Astrocytoma, Untreated Childhood Brain Stem Glioma, Untreated Childhood Giant Cell Glioblastoma, Untreated Childhood Glioblastoma, Untreated Childhood Gliosarcoma
    Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma
    University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Head and Neck Squamous Cell Carcinoma
    FdCyd and THU for Advanced Solid Tumors
    University of Pittsburgh Cancer Center
    Pittsburgh, Pennsylvania 15232
    Neoplasms
    Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Recurrent Childhood Anaplastic Astrocytoma, Recurrent Childhood Anaplastic Oligoastrocytoma, Recurrent Childhood Anaplastic Oligodendroglioma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Diffuse Astrocytoma, Recurrent Childhood Fibrillary Astrocytoma, Recurrent Childhood Gemistocytic Astrocytoma, Recurrent Childhood Giant Cell Glioblastoma, Recurrent Childhood Glioblastoma, Recurrent Childhood Gliomatosis Cerebri, Recurrent Childhood Gliosarcoma, Recurrent Childhood Oligoastrocytoma, Recurrent Childhood Oligodendroglioma, Recurrent Childhood Pilocytic Astrocytoma, Recurrent Childhood Pineoblastoma, Recurrent Childhood Pleomorphic Xanthoastrocytoma, Recurrent Childhood Protoplasmic Astrocytoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma, Recurrent Childhood Visual Pathway and Hypothalamic Glioma, Recurrent Childhood Visual Pathway Glioma, Unspecified Childhood Solid Tumor, Protocol Specific
    Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer
    UPMC Hillman Cancer Center
    Pittsburgh, Pennsylvania 15232
    Colorectal Cancer
    Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer
    Western Pennsylvania Hospital

    Trial Locations
    Western Pennsylvania Hospital
    Allegheny Cancer Center at Allegheny General Hospital
    University of Pittsburgh
    Breast Cancer
    Study With Intensity Modulated Radiation Therapy With Cisplatin to Treat Stage I-IVA Cervical Cancer
    University of Pittsburgh Cancer Center, UPMC
    Pittsburgh, Pennsylvania 15243
    Cervical Cancer
    Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions
    UPMC Hillman Cancer Center
    Pittsburgh, Pennsylvania 15232
    Atypical Nevi, Melanoma
    Stereotactic Radiosurgery or Other Local Ablation Then Erlotinib in Epidermal Growth Factor Receptor (EGFR)
    University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213
    Non Small Cell Lung Cancer
    Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery
    University of Pittsburgh
    Pittsburgh, Pennsylvania 15261
    Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer
    A Phase 3 Trial of Brentuximab Vedotin(SGN-35) Versus Physician's Choice (Methotrexate or Bexarotene) in Patients With CD30-Positive Cutaneous T-Cell Lymphoma
    University of Pittsburgh
    Pittsburgh, Pennsylvania 15261
    Primary Cutaneous Anaplastic Large Cell Lymphoma,, Mycosis Fungoides, Cutaneous T-Cell Lymphoma
    Surgery and Oxaliplatin or Mitomycin C in Treating Patients With Tumors of the Appendix
    UPMC Hillman Cancer Center
    Pittsburgh, Pennsylvania 15232
    Carcinoma of the Appendix, Primary Peritoneal Cavity Cancer
    An Open-label, Multi-center, Expanded Access Study of Pasireotide s.c. in Patients With Cushing's Disease
    Allegheny Endocrinology Associates
    Pittsburgh, Pennsylvania 15212
    Cushing's Disease
    Phase 3 Trial of Autologous Dendritic Cell Immunotherapy (AGS-003) Plus Standard Treatment of Advanced Renal Cell Carcinoma (RCC)
    University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213
    Advanced Renal Cell Carcinoma, Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma
    Combination Chemotherapy With or Without Rituximab in Treating Younger Patients With Stage III-IV Non-Hodgkin Lymphoma or B-Cell Acute Leukemia
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Diffuse Large Cell Lymphoma, L3 Childhood Acute Lymphoblastic Leukemia, Stage III Childhood Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Untreated Childhood Acute Lymphoblastic Leukemia
    Chemotherapy Followed by Radiation Therapy in Treating Younger Patients With Newly Diagnosed Localized Central Nervous System Germ Cell Tumors
    Children's Hospital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15213
    Childhood Central Nervous System Choriocarcinoma, Childhood Central Nervous System Embryonal Tumor, Childhood Central Nervous System Germ Cell Tumor, Childhood Central Nervous System Germinoma, Childhood Central Nervous System Mixed Germ Cell Tumor, Childhood Central Nervous System Teratoma, Childhood Central Nervous System Yolk Sac Tumor, Childhood Pineal Parenchymal Tumor
    Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma
    UPMC Hillman Cancer Center
    Pittsburgh, Pennsylvania 15232
    Melanoma
    Study of PX-866 and Vemurafenib in Patients With Advanced Melanoma
    University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Advanced BRAF-mutant Cancers
    PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score
    St. Clair Hospital
    Pittsburgh, Pennsylvania 15243
    Hormone Receptor Positive Malignant Neoplasm of Breast
    Adult-to-Adult Living Donor Transplant Cohort Study
    University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213
    Liver Diseases, Hepatocellular Cancer, End Stage Liver Disease, Hepatitis C, Liver Cirrhosis
    Multiple Antigen-Engineered DC Vaccine for Melanoma
    University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Melanoma
    Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
    University of Pittsburgh
    Pittsburgh, Pennsylvania 15261
    Adult Primary Hepatocellular Carcinoma, Localized Resectable Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer, Recurrent Adult Primary Liver Cancer
    Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors
    University of Pittsburgh Cancer Institute SC
    Pittsburgh, Pennsylvania 15232
    Pancreatic Neuroendocrine Tumors (pNET)
    A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
    University of Pittsburgh Cancer Institute Dept of Magee Women's Hospital
    Pittsburgh, Pennsylvania 15232
    Metastatic Breast Cancer HR+, HER2-
    Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction
    University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue, Hepatic Complications, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Male Breast Cancer, Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Nodal Marginal Zone B-cell Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Bladder Cancer, Recurrent Breast Cancer, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Lymphoepithelioma of the Oropharynx, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Melanoma, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Pancreatic Cancer, Recurrent Salivary Gland Cancer, Recurrent Small Lymphocytic Lymphoma, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage III Adenoid Cystic Carcinoma of the Oral Cavity, Stage III Basal Cell Carcinoma of the Lip, Stage III Bladder Cancer, Stage III Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage III Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage III Lymphoepithelioma of the Nasopharynx, Stage III Lymphoepithelioma of the Oropharynx, Stage III Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage III Mucoepidermoid Carcinoma of the Oral Cavity, Stage III Pancreatic Cancer, Stage III Salivary Gland Cancer, Stage III Squamous Cell Carcinoma of the Hypopharynx, Stage III Squamous Cell Carcinoma of the Larynx, Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage III Squamous Cell Carcinoma of the Nasopharynx, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage III Verrucous Carcinoma of the Larynx, Stage III Verrucous Carcinoma of the Oral Cavity, Stage IIIA Breast Cancer, Stage IIIA Melanoma, Stage IIIB Breast Cancer, Stage IIIB Melanoma, Stage IIIC Breast Cancer, Stage IIIC Melanoma, Stage IV Bladder Cancer, Stage IV Breast Cancer, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Melanoma, Stage IV Pancreatic Cancer, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity, Stage IVA Basal Cell Carcinoma of the Lip, Stage IVA Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVA Lymphoepithelioma of the Oropharynx, Stage IVA Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVA Mucoepidermoid Carcinoma of the Oral Cavity, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Larynx, Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Verrucous Carcinoma of the Larynx, Stage IVA Verrucous Carcinoma of the Oral Cavity, Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity, Stage IVB Basal Cell Carcinoma of the Lip, Stage IVB Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVB Lymphoepithelioma of the Oropharynx, Stage IVB Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVB Mucoepidermoid Carcinoma of the Oral Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Larynx, Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVB Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Verrucous Carcinoma of the Larynx, Stage IVB Verrucous Carcinoma of the Oral Cavity, Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity, Stage IVC Basal Cell Carcinoma of the Lip, Stage IVC Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVC Lymphoepithelioma of the Oropharynx, Stage IVC Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVC Mucoepidermoid Carcinoma of the Oral Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Larynx, Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IVC Squamous Cell Carcinoma of the Oropharynx, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Verrucous Carcinoma of the Larynx, Stage IVC Verrucous Carcinoma of the Oral Cavity, T-cell Large Granular Lymphocyte Leukemia, Testicular Lymphoma, Tongue Cancer, Waldenström Macroglobulinemia
    Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
    Children's Hospital of Pittsburgh
    Pittsburgh, Pennsylvania 15213
    Transplantation, Liver
    Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
    University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213
    Hepatocellular Carcinoma, Primary Liver Cancer, Bile Duct Cancer, Pancreatic Cancer, Gallbladder Cancer, Colorectal Carcinoma, Liver Metastases
    A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
    Children's Hospital of Pittsburgh
    Pittsburgh, Pennsylvania 15213
    Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma
    NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma
    University of Pittsburgh Medical Center
    Pittsburgh, Pennsylvania 15213
    Renal Cell Carcinoma
    Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)
    Western Pennsylvania Hospital, Site #159
    Pittsburgh, Pennsylvania 15224
    Chronic Myeloid Leukemia
    Tivantinib and Topotecan Hydrochloride in Treating Patients With Advanced or Metastatic Solid Tumors or Recurrent Small Cell Lung Cancer
    University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Recurrent Small Cell Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    Safety Study of Unlicensed, Investigational Cord Blood Units Manufactured by the NCBP for Unrelated Transplantation
    Children's Hopsital of Pittsburgh of UPMC
    Pittsburgh, Pennsylvania 15224
    Infusion Reactions
    Trebananib With or Without Bevacizumab, Pazopanib Hydrochloride, Sorafenib Tosylate, or Sunitinib Malate in Treating Patients With Advanced Kidney Cancer
    University of Pittsburgh Cancer Institute
    Pittsburgh, Pennsylvania 15213
    Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer
    Western Pennsylvania Hospital
    Pittsburgh, Pennsylvania 15224
    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer